The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distribution of breast cancer molecular subtypes within receptor classifications: Lessons from the I-SPY2 Trial and FLEX Registry.
 
Jaeyoon Cha
No Relationships to Disclose
 
Paige Warner
Employment - University of California, San Francisco
 
Robert Hiatt
No Relationships to Disclose
 
Scarlett Lin Gomez
Employment - Bioinspire (I); Valent Technologies (I)
Stock and Other Ownership Interests - Amgen (I); Bioinspire (I)
Consulting or Advisory Role - GRAIL
 
Laura van 't Veer
Employment - Agendia
Stock and Other Ownership Interests - Agendia
 
Allison Stover-Fiscalini
No Relationships to Disclose
 
Alexander Borowsky
Stock and Other Ownership Interests - Histolix
Research Funding - Danaher (Inst)
 
W. Fraser Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; Eiger BioPharmaceuticals; ISIS Pharmaceuticals
Consulting or Advisory Role - Merck
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
(OPTIONAL) Uncompensated Relationships - Delphi Diagnostics
 
Denise M. Wolf
No Relationships to Disclose
 
Christina Yau
No Relationships to Disclose
 
Douglas Yee
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Martell diagnostic
Research Funding - Boehringer Ingelheim
 
Angela DeMichele
Research Funding - Calithera Biosciences (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Donald A. Berry
Other Relationship - Donald Berry is co-owner of Berry Consultants, LLC, a company that designs adaptive Bayesian clinical trials (including I-SPY 2) for pharmaceutical and medical device companies, NIH cooperative groups, patient advocacy groups, and international consortia
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Merck
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative
 
William M. Audeh
No Relationships to Disclose
 
Shraddha Modh
No Relationships to Disclose